Liu, Xia <br/><br/>
Difference of cell cycle arrests induced by lidamycin in human breast cancer cells.  [electronic resource] 

 -  Anti-cancer drugs  Feb 2006 
 - 173-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-4973 
<br/><br/><label>Standard No.: </label>10.1097/00001813-200602000-00008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminoglycosides--pharmacology<br/>Antibiotics, Antineoplastic--pharmacology<br/>Breast Neoplasms--drug therapy<br/>CDC2 Protein Kinase--metabolism<br/>Cell Cycle--drug effects<br/>Checkpoint Kinase 1<br/>Checkpoint Kinase 2<br/>Cyclin B--genetics<br/>Cyclin B1<br/>Cyclin-Dependent Kinase Inhibitor p21--metabolism<br/>Enediynes<br/>Enzyme Activation--drug effects<br/>Gene Expression Regulation, Neoplastic<br/>Genes, Tumor Suppressor--physiology<br/>Humans<br/>Phosphorylation--drug effects<br/>Protein Kinases--metabolism<br/>Protein Serine-Threonine Kinases--metabolism<br/>Retinoblastoma Protein--metabolism<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Protein p53--metabolism